MRI and MRI-targeted biopsy take precedence over systematic biopsy in primary prostate cancer diagnosis
- PMID: 30355658
- DOI: 10.1136/bmjebm-2018-111081
MRI and MRI-targeted biopsy take precedence over systematic biopsy in primary prostate cancer diagnosis
Keywords: diagnostic radiology; genitourinary imaging; magnetic resonance imaging; prostate disease; urological tumours.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.N Engl J Med. 2018 May 10;378(19):1767-1777. doi: 10.1056/NEJMoa1801993. Epub 2018 Mar 18. N Engl J Med. 2018. PMID: 29552975 Free PMC article. Clinical Trial.
Similar articles
-
Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.BJU Int. 2015 Dec;116(6):873-9. doi: 10.1111/bju.13023. Epub 2015 Apr 27. BJU Int. 2015. PMID: 25523210
-
Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.Eur Urol. 2016 Mar;69(3):512-7. doi: 10.1016/j.eururo.2015.06.005. Epub 2015 Jun 22. Eur Urol. 2016. PMID: 26112001 Free PMC article.
-
Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy.BJU Int. 2016 Aug;118(2):213-20. doi: 10.1111/bju.13461. Epub 2016 Apr 2. BJU Int. 2016. PMID: 26935133
-
Role of MRI prebiopsy in men at risk for prostate cancer: taking off the blindfold.Curr Opin Urol. 2017 May;27(3):246-253. doi: 10.1097/MOU.0000000000000389. Curr Opin Urol. 2017. PMID: 28234749 Review.
-
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group.Eur Urol. 2013 Oct;64(4):544-52. doi: 10.1016/j.eururo.2013.03.030. Epub 2013 Mar 20. Eur Urol. 2013. PMID: 23537686
Cited by
-
Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis.Int J Mol Sci. 2019 Apr 2;20(7):1637. doi: 10.3390/ijms20071637. Int J Mol Sci. 2019. PMID: 30986955 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical